Action Summary | Specialty pharmaceuticals represent the fastest growing segment of the prescription drug market in the U.S. Industry projections have the growth rate at 20% per year. Typically, these products are used to treat chronic and/or rare diseases, are high-cost, and can be administered by injection, infusion inhalation, or orally. DMAS is promulgating this regulation in an effort to help contain the costs of these complex and expensive drugs. |
Chapters Affected | Only affects this chapter. |
Executive Branch Review | This action will go through the normal Executive Branch Review process. |
RIS Project | Yes [001319] |
New Periodic Review | This action will not be used to conduct a new periodic review. |
Name / Title: | Keith Hayashi / Health Care Services Division -- Pharmacy |
Address: |
600 East Broad Street Suite 1300 Richmond, VA 23219 |
Email Address: | Keith.Hayashi@dmas.virginia.gov |
Phone: | (804)225-2773 FAX: (804)786-1680 TDD: ()- |